Metabolomics and Network Pharmacology-Based Investigation into the Mechanisms Underlying the Therapeutic Effect of a New Chinese Traditional Medicine (Cui Nai Ling) on Bromocriptine-Induced Hypogalactia

Figure 3

Differential metabolite analysis of serum. The PCA analysis in different groups (a) and OPLS-DA analysis between control and normal (b), NCNLL (c), NCNLH (d), and CNL (e) treatment groups. The permutation test of the OPLS-DA mode between control and normal (f), NCNLL (g), NCNLH (h), and CNL (i) treatment groups. The S-plot analysis between control and normal (j), NCNLL (k), NCNLH (l), and CNL (m) treatment groups. The summary of pathway analysis of differential metabolites between control and normal (n) and NCNLH (o).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)